Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
236.4 CHF | -0.17% | -2.23% | -9.56% |
08:48am | Nykode Therapeutics Launches Phase 2 Clinical Trial for Cervical Cancer Vaccine | MT |
07:29am | Roche's Lung-Cancer Drug Alecensa Gets New FDA Approval | DJ |
Sales 2024 * | 59.84B 65.9B | Sales 2025 * | 63.41B 69.83B | Capitalization | 177B 195B |
---|---|---|---|---|---|
Net income 2024 * | 13.38B 14.73B | Net income 2025 * | 14.66B 16.14B | EV / Sales 2024 * | 3.19 x |
Net Debt 2024 * | 13.47B 14.83B | Net Debt 2025 * | 7.31B 8.05B | EV / Sales 2025 * | 2.91 x |
P/E ratio 2024 * |
13.1
x | P/E ratio 2025 * |
11.9
x | Employees | 103,605 |
Yield 2024 * |
4.36% | Yield 2025 * |
4.54% | Free-Float | 88.91% |
Latest transcript on Roche Holding AG
1 day | -0.63% | ||
1 week | -2.23% | ||
Current month | -2.72% | ||
1 month | -2.15% | ||
3 months | -10.25% | ||
6 months | -6.41% | ||
Current year | -9.56% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 02-12-31 | |
Severin Schwan
CHM | Chairman | 57 | 07-12-31 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 11-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 15-03-02 |
Director/Board Member | 59 | - | |
Director/Board Member | 65 | 95-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.06% | 2 M€ | -.--% | - | |
2.06% | 2 M€ | +9.19% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 236.4 | -0.17% | 5 339 |
24-04-18 | 236.8 | -0.25% | 27,764 |
24-04-17 | 237.4 | -0.17% | 28,903 |
24-04-16 | 237.8 | -1.98% | 22,820 |
24-04-15 | 242.6 | +0.33% | 28,997 |
Delayed Quote Swiss Exchange, April 19, 2024 at 03:26 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.97% | 672B | |
+23.62% | 550B | |
-7.02% | 351B | |
+14.85% | 317B | |
+6.25% | 292B | |
+2.47% | 211B | |
-0.66% | 203B | |
-11.81% | 144B | |
-8.80% | 141B |
- Stock Market
- Equities
- ROG Stock
- RO Stock